A detailed history of Advisor Group Holdings, Inc. transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 14,210 shares of ACXP stock, worth $12,504. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,210
Previous 15,210 6.57%
Holding current value
$12,504
Previous $34,000 23.53%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.83 - $2.62 $1,830 - $2,620
-1,000 Reduced 6.57%
14,210 $26,000
Q2 2024

Aug 13, 2024

SELL
$1.64 - $2.79 $68,945 - $117,291
-42,040 Reduced 73.43%
15,210 $34,000
Q4 2023

Feb 12, 2024

BUY
$1.28 - $5.76 $40,000 - $180,000
31,250 Added 120.19%
57,250 $219,000
Q3 2023

Nov 13, 2023

BUY
$1.41 - $2.55 $5,640 - $10,200
4,000 Added 18.18%
26,000 $39,000
Q2 2023

Aug 10, 2023

BUY
$2.47 - $3.53 $14,820 - $21,180
6,000 Added 37.5%
22,000 $58,000
Q1 2023

May 12, 2023

BUY
$3.06 - $4.5 $12,240 - $18,000
4,000 Added 33.33%
16,000 $55,000
Q3 2022

Nov 14, 2022

BUY
$3.0 - $4.78 $3,000 - $4,780
1,000 Added 9.09%
12,000 $36,000
Q2 2022

Aug 10, 2022

BUY
$2.42 - $4.0 $26,620 - $44,000
11,000 New
11,000 $42,000
Q1 2022

May 04, 2022

SELL
$3.11 - $4.74 $9,330 - $14,220
-3,000 Closed
0 $0
Q3 2021

Nov 05, 2021

BUY
$3.77 - $6.18 $11,310 - $18,540
3,000 New
3,000 $15,000

Others Institutions Holding ACXP

About Acurx Pharmaceuticals, Inc.


  • Ticker ACXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,556,600
  • Market Cap $10.2M
  • Description
  • Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...
More about ACXP
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.